Here are six things to know.
1. A federal jury in New York City convicted the two men on charges of wire fraud and conspiracy to commit money laundering.
2. Prosecutors claim Mr. Tanner, who was responsible for managing Valeant’s relationship with the mail-order pharmacy, funneled business to Philidor to increase sales and “evade insurers’ efforts to substitute cheaper generic versions for expensive Valeant medications,” according to NYT.
3. Mr. Davenport also allegedly paid Mr. Tanner about $10 million and took $40 million for himself when Valeant exercised an option to purchase Philidor.
4. The two executives kept the arrangement under wraps by using shell companies and emailing each other with fake names, prosecutors said.
5. Lawyers for Mr. Tanner and Mr. Davenport denied any wrongdoing during the three-week trial. While Mr. Davenport’s lawyers did not immediately respond to NYT‘s request for comment, Mr. Tanner’s lawyers said they were disappointed by the verdict and planned to appeal.
6. Mr. Tanner and Mr. Davenport’s sentencing is set for Sept. 19. They each face up to 65 years in prison, a U.S. Department of Justice spokesperson told NYT.
More articles on legal and regulatory issues:
3 former execs at medical billing company face criminal charges in $300M investment fraud scheme
Physician indicted in illegal opioid distribution case, faces up to 390 years in prison
Nicklaus Children’s Hospital sues Florida to stop opening of competing trauma center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
